Metavention

Metavention is a developer of diabetes treatment methods, focusing on the development of transcatheter metabolic neuromodulation therapies. These therapies regulate the activity of sympathetic nerves associated with elevated blood sugar and abnormal liver function to achieve therapeutic goals such as blood sugar control. This approach has the potential to provide substantial benefits for metabolic diseases like T2D (Type 2 Diabetes) and non-alcoholic fatty liver disease. Doctors insert a catheter into the body through femoral artery puncture, then guide the MNT (Metabolic Neuromodulation Therapy) device into the hepatic vessels. After proper positioning, radiofrequency energy is emitted to penetrate the vessel walls and ablate the target sympathetic nerves near the vessels, reducing sympathetic nerve tension in metabolic organs.